WallStreetZenWallStreetZen

NASDAQ: ESTA
Establishment Labs Holdings Inc Stock

$45.39-3.68 (-7.5%)
Updated Oct 2, 2023
ESTA Price
$45.39
Fair Value Price
$47.13
Market Cap
$1.17B
52 Week Low
$44.03
52 Week High
$79.88
P/E
-18.6x
P/B
21.32x
P/S
9.92x
PEG
N/A
Dividend Yield
N/A
Revenue
$177.14M
Earnings
-$60.86M
Gross Margin
64.7%
Operating Margin
-24.97%
Profit Margin
-34.4%
Debt to Equity
4.2
Operating Cash Flow
-$85M
Beta
1.15
Next Earnings
Nov 6, 2023
Ex-Dividend
N/A
Next Dividend
N/A

ESTA Overview

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ESTA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ESTA ($45.39) is undervalued by 3.69% relative to our estimate of its Fair Value price of $47.13 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ESTA ($45.39) is not significantly undervalued (3.69%) relative to our estimate of its Fair Value price of $47.13 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ESTA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ESTA due diligence checks available for Premium users.

Be the first to know about important ESTA news, forecast changes, insider trades & much more!

ESTA News

Valuation

ESTA fair value

Fair Value of ESTA stock based on Discounted Cash Flow (DCF)
Price
$45.39
Fair Value
$47.13
Undervalued by
3.69%
ESTA ($45.39) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ESTA ($45.39) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ESTA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ESTA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-18.6x
Industry
48.83x
Market
12.38x

ESTA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
21.32x
Industry
3.47x
ESTA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ESTA's financial health

Profit margin

Revenue
$48.6M
Net Income
-$16.7M
Profit Margin
-34.5%
ESTA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ESTA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$285.3M
Liabilities
$230.4M
Debt to equity
4.2
ESTA's short-term assets ($209.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ESTA's short-term assets ($209.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ESTA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ESTA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$28.2M
Investing
-$9.0M
Financing
$84.5M
ESTA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ESTA vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
ESTA$1.17B-7.50%-18.60x21.32x
AHCO$1.22B-1.43%29.90x0.56x
UFPT$1.22B-0.91%24.50x4.70x
QTRX$1.00B-1.58%-15.18x2.82x
FNA$995.49M-3.90%-13.70x5.00x

Establishment Labs Holdings Stock FAQ

What is Establishment Labs Holdings's quote symbol?

(NASDAQ: ESTA) Establishment Labs Holdings trades on the NASDAQ under the ticker symbol ESTA. Establishment Labs Holdings stock quotes can also be displayed as NASDAQ: ESTA.

If you're new to stock investing, here's how to buy Establishment Labs Holdings stock.

What is the 52 week high and low for Establishment Labs Holdings (NASDAQ: ESTA)?

(NASDAQ: ESTA) Establishment Labs Holdings's 52-week high was $79.88, and its 52-week low was $44.03. It is currently -43.18% from its 52-week high and 3.1% from its 52-week low.

How much is Establishment Labs Holdings stock worth today?

(NASDAQ: ESTA) Establishment Labs Holdings currently has 25,775,666 outstanding shares. With Establishment Labs Holdings stock trading at $45.39 per share, the total value of Establishment Labs Holdings stock (market capitalization) is $1.17B.

Establishment Labs Holdings stock was originally listed at a price of $24.75 in Jul 19, 2018. If you had invested in Establishment Labs Holdings stock at $24.75, your return over the last 5 years would have been 83.39%, for an annualized return of 12.9% (not including any dividends or dividend reinvestments).

How much is Establishment Labs Holdings's stock price per share?

(NASDAQ: ESTA) Establishment Labs Holdings stock price per share is $45.39 today (as of Oct 2, 2023).

What is Establishment Labs Holdings's Market Cap?

(NASDAQ: ESTA) Establishment Labs Holdings's market cap is $1.17B, as of Oct 4, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Establishment Labs Holdings's market cap is calculated by multiplying ESTA's current stock price of $45.39 by ESTA's total outstanding shares of 25,775,666.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.